Harvard Bioscience, Inc. (NASDAQ:HBIO) Q1 2023 Earnings Call Transcript April 25, 2023
Harvard Bioscience, Inc. beats earnings expectations. Reported EPS is $0.06, expectations were $0.05.
Operator: Good day, and thank you for standing by. Welcome to Harvard Bioscience First Quarter 2023 Earnings Conference Call. Please be advised that today’s conference is being recorded. I would now like to hand the conference over to your speaker today, Dave Sirois, Director of — SEC Director. Please go...
